paper-with-me

홈 › Papers

Artificial Intelligence in Ovarian Cancer Histopathology: A Systematic Review

2023-03-31 · Jack Breen, Katie Allen, Kieran Zucker, Pratik Adusumilli, Andy Scarsbrook, Geoff Hall, Nicolas M. Orsi, Nishant Ravikumar

Purpose - To characterise and assess the quality of published research evaluating artificial intelligence (AI) methods for ovarian cancer diagnosis or prognosis using histopathology data. Methods - A search of PubMed, Scopus, Web of Science, CENTRAL, and WHO-ICTRP was conducted up to 19/05/2023. The inclusion criteria required that research evaluated AI on histopathology images for diagnostic or prognostic inferences in ovarian cancer. The risk of bias was assessed using PROBAST. Information about each model of interest was tabulated and summary statistics were reported. PRISMA 2020 reporting guidelines were followed. Results - 1573 records were identified, of which 45 were eligible for inclusion. There were 80 models of interest, including 37 diagnostic models, 22 prognostic models, and 21 models with other diagnostically relevant outcomes. Models were developed using 1-1375 slides from 1-776 ovarian cancer patients. Model outcomes included treatment response (11/80), malignancy status (10/80), stain quantity (9/80), and histological subtype (7/80). All models were found to be at high or unclear risk of bias overall, with most research having a high risk of bias in the analysis and a lack of clarity regarding participants and predictors in the study. Research frequently suffered from insufficient reporting and limited validation using small sample sizes. Conclusion - Limited research has been conducted on the application of AI to histopathology images for diagnostic or prognostic purposes in ovarian cancer, and none of the associated models have been demonstrated to be ready for real-world implementation. Key aspects to help ensure clinical translation include more transparent and comprehensive reporting of data provenance and modelling approaches, as well as improved quantitative performance evaluation using cross-validation and external validations.

📄 PDF Abstract BibTeX arXiv:2303.18005

Code (1)

scjjb/ovcareview 공식 구현

Tasks

DiagnosticPrognosisSurvival Prediction

Methods 이 논문이 사용한 방법론

None 설명 없음

Similar Papers 제목 키워드 기반

Reducing Histopathology Slide Magnification Improves the Accuracy and Speed of Ovarian Cancer Subtyping

2023-11-23 · Jack Breen, Katie Allen, Kieran Zucker, Nicolas M. Orsi 외

Artificial intelligence has found increasing use for ovarian cancer morphological subtyping from histopathology slides, but the optimal magnification for computational interpretation is unclear. Higher magnifications off…

Multiple Instance Learning

A Comprehensive Evaluation of Histopathology Foundation Models for Ovarian Cancer Subtype Classification

2024-05-16 · Jack Breen, Katie Allen, Kieran Zucker, Lucy Godson 외

Large pretrained transformers are increasingly being developed as generalised foundation models which can underpin powerful task-specific artificial intelligence models. Histopathology foundation models show great promis…

Multiple Instance Learningwhole slide images

Pan-Cancer Diagnostic Consensus Through Searching Archival Histopathology Images Using Artificial Intelligence

2019-11-20 · Shivam Kalra, H. R. Tizhoosh, Sultaan Shah, Charles Choi 외

The emergence of digital pathology has opened new horizons for histopathology and cytology. Artificial-intelligence algorithms are able to operate on digitized slides to assist pathologists with diagnostic tasks. Whereas…

DiagnosticGPUImage Retrievalwhole slide images

Automated Detection of Malignant Lesions in the Ovary Using Deep Learning Models and XAI

2026-03-12 · Md. Hasin Sarwar Ifty, Nisharga Nirjan, Labib Islam, M. A. Diganta 외 arxiv

The unrestrained proliferation of cells that are malignant in nature is cancer. In recent times, medical professionals are constantly acquiring enhanced diagnostic and treatment abilities by implementing deep learning mo…

Drug Discovery

Benchmarking Histopathology Foundation Models for Ovarian Cancer Bevacizumab Treatment Response Prediction from Whole Slide Images

2024-07-30 · Mayur Mallya, Ali Khajegili Mirabadi, Hossein Farahani, Ali Bashashati

Bevacizumab is a widely studied targeted therapeutic drug used in conjunction with standard chemotherapy for the treatment of recurrent ovarian cancer. While its administration has shown to increase the progression-free …

BenchmarkingMultiple Instance LearningPrognosiswhole slide images